Safety Alert Or Field Safety Notices for JM103 and JM105 Jaundice Meters

According to Medicines and Healthcare products Regulatory Agency, this safety alert or field safety notices involved a device in United Kingdom that was produced by Draeger Medical Systems.

What is this?

Field safety notices are communications sent out by medical device manufacturers or their representatives in relation to actions that they may be taking in relation to their product that is on the market. These are mainly for health workers, but also for users. They can include recalls and alerts.

Learn more about the data here
  • Type of Event
    Safety alert / Field Safety Notice
  • Date
    2018-06-11
  • Event Date Posted
    2018-06-11
  • Event Country
  • Event Source
    MHRA
  • Event Source URL
  • Notes / Alerts
    Data from the United Kingdom is current through April 2019. All of the data comes from the Medicines and Healthcare products Regulatory Agency, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and the United Kingdom.
  • Extra notes in the data
    In response to measuring values of bilirubin greater than 340 µmol/l or 20.0 mg/dl, the JM103 will display a flashing “- - -“error message whilst the JM105 will display a flashing “- 0 -“ error message. Misinterpretation of these messages has led to delay of treatment for jaundice in neonates. The manufacturer is supplying information labels to apply to these devices to clarify the meaning of these error messages.The manufacturer will make a firmware upgrade available for JM105 devices that will allow the user to set the error message displayed in these circumstances to “>340 µmol/l” or “>20 mg/dl” or “- 0 -“. Organisations with JM105 devices will be contacted by the manufacturer via a Field Safety Notice to offer this upgrade which will be free of charge for all devices. The MHRA advises that this update is applied and option “- 0 -“ is not used.
  • Reason
    Draeger medical systems – misinterpretation of display may cause delay of treatment of neonatal jaundice.
  • Action
    Identify any JM103 and JM105 devices in your organisation. Complete the “Confirmation of Receipt” form and the “Label Address Confirmation” form sent to you with the Safety Notice and return it to the manufacturer so that the warning stickers can be sent to you. Apply the warning stickers to the devices. Ensure there are systems in place so that users are trained to follow the Instructions for Use supplement (“Sample Usage Protocol Template”) in the Field Safety Notices for the JM103 and JM105. If you possess JM105 devices, the manufacturer will contact you to arrange a firmware upgrade, once available, to improve the out-of-range error message. It should be installed on all JM105 devices and will be free-of-charge. It is therefore essential that you provide the manufacturer with your contact details.

Device

Manufacturer

  • Manufacturer Address
    Draeger Medical UK Ltd Helen Glass Tel: 01442 292870helen.glass@draeger.com
  • Manufacturer Parent Company (2017)
  • Source
    MHRA